Mutant thyroid hormone receptors (TRs) isolated from distinct cancer types display distinct target gene specificities: A unique regulatory repertoire associated with two renal clear cell carcinomas

Molecular Endocrinology

Volumn 25, Issue 8, 2011, Pages 1311-1325

  Rosen, Meghan D ^a   Chan, Ivan H ^a   Privalsky, Martin L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

THYROID HORMONE RECEPTOR;

ARTICLE; CLEAR CELL CARCINOMA; CONTROLLED STUDY; ENERGY METABOLISM; GENE TARGETING; GLYCOLYSIS; HUMAN; HUMAN CELL; KIDNEY CARCINOMA; LIVER CELL CARCINOMA; MUTANT; MUTATION; PHENOTYPE; PRIORITY JOURNAL; WILD TYPE;

CARCINOMA, HEPATOCELLULAR; CARCINOMA, RENAL CELL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, NEOPLASM; HEP G2 CELLS; HUMANS; KIDNEY NEOPLASMS; LIVER NEOPLASMS; MUTANT PROTEINS; RECEPTORS, THYROID HORMONE; REPRESSOR PROTEINS; TRANSCRIPTION, GENETIC; TRANSCRIPTIONAL ACTIVATION; TRIIODOTHYRONINE;

EID: 79960997523     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2010-0420     Document Type: Article

References (65)

1. Katz RW, Koenig RJ. 1993. Nonbiased identification of DNA sequences that bind thyroid hormone receptor α 1 with high affinity. J Biol Chem. 268:19392-19397
2. Lazar MA. 1993. Thyroid hormone receptors: multiple forms, multiple possibilities. Endocr Rev 14:184-193
3. Lazar MA. 2003. Thyroid hormone action: a binding contract. J Clin Invest 112:497-499
4. Yen PM. 2001. Physiological and molecular basis of thyroid hormone action. Physiol Rev. 81:1097-1142
5. Cheng SY. 2000. Multiple mechanisms for regulation of the transcriptional activity of thyroid hormone receptors. Rev Endocr Metab Disord 1:9-18
6. Zhang J, Lazar MA. 2000. The mechanism of action of thyroid hormones. Annu Rev Physiol 62:439-466
7. Harvey CB, Williams GR. 2002 Mechanism of thyroid hormone action. Thyroid 12:441-446
8. Hollenberg AN, Monden T, Flynn TR, Boers ME, Cohen O, Won-disford FE. 1995. The human thyrotropin-releasing hormone gene is regulated by thyroid hormone through two distinct classes of negative thyroid hormone response elements. Mol Endocrinol 9:540-550
9. Nygård M, Wahlstrom GM, Gustafsson MV, Tokumoto YM, Bondesson M. 2003. Hormone-dependent repression of the E2F-1 gene by thyroid hormone receptors. Mol Endocrinol 17:79-92
10. Decherf S, Seugnet I, Kouidhi S, Lopez-Juarez A, Clerget-Froidevaux MS, Demeneix BA. 2010. Thyroid hormone exerts negative feedback on hypothalamic type 4 melanocortin receptor expression. Proc Natl Acad Sci USA 107:4471-4476
11. Chan IH, Privalsky ML. 2009. Thyroid hormone receptor mutants implicated in human hepatocellular carcinoma display an altered target gene repertoire. Oncogene 28:4162-4174
12. Aranda A, Pascual A 2001 Nuclear hormone receptors and gene expression. Physiol Rev 81:1269-1304
13. Lee JW, Lee YC, Na SY, Jung DJ, Lee SK 2001 Transcriptional coregulators of the nuclear receptor superfamily: coactivators and corepressors. Cell Mol Life Sci 58:289-297
14. Jones PL, Shi YB. 2003. N-CoR-HDAC corepressor complexes: roles in transcriptional regulation by nuclear hormone receptors. Curr Top Microbiol Immunol 274:237-268
15. Privalsky ML. 2004 The role of corepressors in transcriptional regulation by nuclear hormone receptors. Annu Rev Physiol 66:315-360
16. Forrest D, Erway LC, Ng L, Altschuler R, Curran T. 1996 Thyroid hormone receptor beta is essential for development of auditory function. Nat Genet 13:354-357
17. Wikstrom L, Johansson C, Salto C, Barlow C, Campos Barros A, Baas F, Forrest D, Thoren P, Vennstrom B. 1998. Abnormal heart rate and body temperature in mice lacking thyroid hormone receptor α 1. EMBO J 17:455-461
18. Ng L, Hurley JB, Dierks B, Srinivas M, Salto C, Vennstrom B, Reh TA, Forrest D. 2001. A thyroid hormone receptor that is required for the development of green cone photoreceptors. Nat Genet 27: 94-98
19. Oetting A, Yen PM. 2007. New insights into thyroid hormone action. Best Pract Res Clin Endocrinol Metab 21:193-208
20. Cheng SY, Leonard JL, Davis PJ. 2010. Molecular aspects of thyroid hormone actions. Endocr Rev 31:139-170
21. García-Silva S, Aranda A. 2004. The thyroid hormone receptor is a suppressor of ras-mediated transcription, proliferation, and transformation. Mol Cell Biol 24:7514-7523
22. Martínez-Iglesias O, Garcia-Silva S, Tenbaum SP, Regadera J, Larcher F, Paramio JM, Vennstrom B, Aranda A. 2009. Thyroid hormone receptor β1 acts as a potent suppressor of tumor invasiveness and metastasis. Cancer Res 69:501-509
23. Zhu XG, Zhao L, Willingham MC, Cheng SY. 2010. Thyroid hormone receptors are tumor suppressors in a mouse model of metastatic follicular thyroid carcinoma. Oncogene 29:1909-1919
24. Lin KH, Shieh HY, Chen SL, Hsu HC. 1999. Expression of mutant thyroid hormone nuclear receptors in human hepatocellular carcinoma cells. Mol Carcinog 26:53-61
25. Kamiya Y, Puzianowska-Kuznicka M, McPhie P, Nauman J, Cheng SY, Nauman A. 2002. Expression of mutant thyroid hormone nuclear receptors is associated with human renal clear cell carcinoma. Carcinogenesis 23:25-33
26. Puzianowska-Kuznicka M, Krystyniak A, Madej A, Cheng SY, Nauman J. 2002. Functionally impaired TR mutants are present in thyroid papillary cancer. J Clin Endocrinol Metab 87:1120-1128
27. Wang CS, Lin KH, Hsu YC. 2002. Alterations of thyroid hormone receptor a gene: frequency and association with Nm23 protein expression and metastasis in gastric cancer. Cancer Lett 175:121-127
28. Cheng SY. 2003. Thyroid hormone receptor mutations in cancer. Mol Cell Endocrinol 213:23-30
29. Vennstrom B, Bishop JM. 1982. Isolation and characterization of chicken DNA homologous to the two putative oncogenes of avian erythroblastosis virus. Cell 28:135-143
30. Graf T, Beug H. 1983. Role of the v-erbA and v-erbB oncogenes of avian erythroblastosis virus in erythroid cell transformation. Cell 34:7-9
31. Sap J, Muñoz A, Damm K, Goldberg Y, Ghysdael J, Leutz A, Beug H, Vennstrom B. 1986. The c-erb-A protein is a high-affinity receptor for thyroid hormone. Nature 324:635-640
32. Weinberger C, Thompson CC, Ong ES, Lebo R, Gruol DJ, Evans RM. 1986. The c-erb-A gene encodes a thyroid hormone receptor. Nature 324:641-646
33. Kahn P, Frykberg L, Brady C, Stanley I, Beug H, Vennstrom B, Graf T. 1986. V-erbA cooperates with sarcoma oncogenes in leukemic cell transformation. Cell 45:349-356
34. Damm K, Thompson CC, Evans RM. 1989. Protein encoded by v-erbA functions as a thyroid-hormone receptor antagonist. Nature 339:593-597
35. Privalsky ML. 1992. V-erb A, nuclear hormone receptors, and oncogenesis. Biochim Biophys Acta 1114:51-62
36. Refetoff S, Weiss RE, Usala SJ. 1993. The syndromes of resistance to thyroid hormone. Endocr Rev 14:348-399
37. Kopp P, Kitajima K, Jameson JL. 1996. Syndrome of resistance to thyroid hormone: insights into thyroid hormone action. Proc Soc Exp Biol Med 211:49-61
38. Yen PM. 2003. Molecular basis of resistance to thyroid hormone. Trends Endocrinol Metab 14:327-333
39. Chan IH, Privalsky ML. 2006. Thyroid hormone receptors mutated in liver cancer function as distorted antimorphs. Oncogene 25: 3576-3588
40. Darby IA, Bouhnik J, Coezy ED, Corvol P. 1991. Thyroid hormone receptors and stimulation of angiotensinogen production in HepG2 cells. In Vitro Cell Dev Biol 27:21-24
41. Nozaki S, Shimomura I, Funahashi T, Menju M, Kubo M, Matsu-zawa Y. 1992. Stimulation of the activity and mRNA level of hepatic triacylglycerol lipase by triiodothyronine in HepG2 cells. Biochim Biophys Acta 1127:298-302
42. Theriault A, Ogbonna G, Adeli K 1992 Thyroid hormone modulates apolipoprotein B gene expression in HepG2 cells. Biochem Biophys Res Commun 186:617-623
43. Chamba A, Neuberger J, Strain A, Hopkins J, Sheppard MC, Franklyn JA. 1996. Expression and function of thyroid hormone receptor variants in normal and chronically diseased human liver. J Clin Endocrinol Metab 81:360-367
44. Lin KH, Zhu XG, Shieh HY, Hsu HC, Chen ST, McPhie P, Cheng SY. 1996. Identification of naturally occurring dominant negative mutants of thyroid hormone a 1 and β 1 receptors in a human hepatocellular carcinoma cell line. Endocrinology 137: 4073-4081
45. Rosen MD, Privalsky ML. 2009. Thyroid hormone receptor mutations found in renal clear cell carcinomas alter corepressor release and reveal helix 12 as key determinant of corepressor specificity. Mol Endocrinol 23:1183-1192
46. Wan W, Farboud B, Privalsky ML. 2005. Pituitary resistance to thyroid hormone syndrome is associated with T3 receptor mutants that selectively impair β2 isoform function. Mol Endocrinol 19: 1529-1542
47. Refetoff S, Weiss RE, Wing JR, Sarne D, Chyna B, Hayashi Y. 1994. Resistance to thyroid hormone in subjects from two unrelated families is associated with a point mutation in the thyroid hormone receptor β gene resulting in the replacement of the normal proline 453 with serine. Thyroid 4:249-254
48. Lin BC, Hong SH, Krig S, Yoh SM, Privalsky ML. 1997. A conformational switch in nuclear hormone receptors is involved in coupling hormone binding to corepressor release. Mol Cell Biol 17: 6131-6138
49. Lee S, Privalsky ML. 2005. Multiple mutations contribute to repression by the v-Erb A oncoprotein. Oncogene 24:6737-6752
50. Takahashi M, Teh BT, Kanayama HO. 2006. Elucidation of the molecular signatures of renal cell carcinoma by gene expression profiling. J Med Invest 53:9-19
51. Dalgliesh GL, Furge K, Greenman C, Chen L, Bignell G, Butler A, Davies H, Edkins S, Hardy C, Latimer C, Teague J, Andrews J, Barthorpe S, Beare D, Buck G, Campbell PJ, Forbes S, Jia M, Jones D, Knott H, Kok CY, Lau KW, Leroy C, Lin ML, McBride DJ, et al. 2010. Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes. Nature 463:360-363
52. Takahashi M, Yang XJ, Sugimura J, Backdahl J, Tretiakova M, Qian CN, Gray SG, Knapp R, Anema J, Kahnoski R, Nicol D, Vogelzang NJ, Furge KA, Kanayama H, Kagawa S, Teh BT. 2003. Molecular subclassification of kidney tumors and the discovery of new diagnostic markers. Oncogene 22:6810-6818
53. Latif F, Tory K, Gnarra J, Yao M, Duh FM, Orcutt ML, Stack-house T, Kuzmin I, Modi W, Geil L. 1993. Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 260: 1317-1320
54. Maxwell PH, Wiesener MS, Chang GW, Clifford SC, Vaux EC, Cockman ME, Wykoff CC, Pugh CW, Maher ER, Ratcliffe PJ. 1999. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399: 271-275
55. Stebbins CE, Kaelin Jr WG, Pavletich NP. 1999. Structure of the VHL-ElonginC-ElonginB complex: implications for VHL tumor suppressor function. Science 284:455-461
56. Linehan WM, Rubin JS, Bottaro DP. 2009. VHL loss of function and its impact on oncogenic signaling networks in clear cell renal cell carcinoma. Int J Biochem Cell Biol 41:753-756
57. Linehan WM, Bratslavsky G, Pinto PA, Schmidt LS, Neckers L, Bottaro DP, Srinivasan R. 2010. Molecular diagnosis and therapy of kidney cancer. Annu Rev Med 61:329-343
58. Wick M, Burger C, Funk M, Muller R. 1995. Identification of a novel mitogen-inducible gene (mig-6): regulation during G1 progression and differentiation. Exp Cell Res 219:527-535
59. Lin KR, Lee SF, Hung CM, Li CL, Yang-Yen HF, Yen JJ. 2007. Survival factor withdrawal-induced apoptosis of TF-1 cells involves a TRB2-Mcl-1 axis-dependent pathway. J Biol Chem 282:21962-21972
60. Datta J, Majumder S, Kutay H, Motiwala T, Frankel W, Costa R, Cha HC, MacDougald OA, Jacob ST, Ghoshal K. 2007. Metallo-thionein expression is suppressed in primary human hepatocellular carcinomas and is mediated through inactivation of CCAAT/en-hancer binding protein a by phosphatidylinositol 3-kinase signaling cascade. Cancer Res 67:2736-2746
61. Tao X, Zheng JM, Xu AM, Chen XF, Zhang SH. 2007. Down-regulated expression of metallothionein and its clinicopathological significance in hepatocellular carcinoma. Hepatol Res 37:820-827
62. Kanda M, Nomoto S, Okamura Y, Nishikawa Y, Sugimoto H, Kanazumi N, Takeda S, Nakao A. 2009. Detection of metallothionein 1G as a methylated tumor suppressor gene in human hepato-cellular carcinoma using a novel method of double combination array analysis. Int J Oncol 35:477-483
63. Ventura-Holman T, Mamoon A, Subauste JS. 2008. Modulation of expression of RA-regulated genes by the oncoprotein verbA. Gene 425:23-27
64. Chan IH, Privalsky ML. 2009. Isoform-specific transcriptional activity of overlapping target genes that respond to thyroid hormone receptors α1 and β1. Mol Endocrinol 23:1758-1775
65. Krzywinski M, Schein J, Birol I, Connors J, Gascoyne R, Horsman D, Jones SJ, Marra MA. 2009. Circos: an information aesthetic for comparative genomics. Genome Res 19:1639-1645